Data for: Comparative Assessment of Outcomes in Drug Treatment for Smoking Cessation and Role of Genetic Polymorphisms of Human Nicotinic Acetylcholine Receptor Subunits

The data of this manuscript entitled “Comparative Assessment of Outcomes in Drug Treatment for Smoking Cessation and Role of Genetic Polymorphisms of Human Nicotinic Acetylcholine Receptor Subunits” by Muderrisoglu et. al., 2022 is presented in this file. In the study, the effects of functional genetic polymorphisms of nicotinic acetylcholine receptor subunits on smoking status and success of cessation treatments in a Turkish population of non-smokers and smokers treated with nicotine replacement, bupropion or varenicline were investigated.

本文件收录了Muderrisoglu等人2022年发表的题为《烟瘾药物治疗结局对比评估及人类烟碱型乙酰胆碱受体亚基（nicotinic acetylcholine receptor subunits）基因多态性的作用》的手稿相关数据。该研究以土耳其人群为研究对象，针对接受尼古丁替代疗法（nicotine replacement）、安非他酮（bupropion）或伐尼克兰（varenicline）治疗的非吸烟者与吸烟者，探究了烟碱型乙酰胆碱受体亚基的功能性基因多态性对吸烟状态及戒烟治疗成功率的影响。